New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with ...
All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...
Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a ...
US Bancorp DE reduced its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 55.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The ...
Seeing a loved one pass out with their eyes rolled back is a terrifying thing to experience. That minute or two you li ...
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...